These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26699619)
21. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis. Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190 [TBL] [Abstract][Full Text] [Related]
22. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. Susser S; Herrmann E; Lange C; Hamdi N; Müller T; Berg T; Perner D; Zeuzem S; Sarrazin C PLoS One; 2014; 9(11):e112592. PubMed ID: 25393304 [TBL] [Abstract][Full Text] [Related]
23. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111 [TBL] [Abstract][Full Text] [Related]
24. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C. Fujino H; Imamura M; Nagaoki Y; Kawakami Y; Abe H; Hayes CN; Kan H; Fukuhara T; Kobayashi T; Masaki K; Ono A; Nakahara T; Honda Y; Naeshiro N; Urabe A; Yokoyama S; Miyaki D; Murakami E; Kawaoka T; Hiraga N; Tsuge M; Hiramatsu A; Hyogo H; Aikata H; Takahashi S; Miki D; Ochi H; Ohishi W; Chayama K; J Gastroenterol; 2014 Dec; 49(12):1548-56. PubMed ID: 24362944 [TBL] [Abstract][Full Text] [Related]
25. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection? Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970 [TBL] [Abstract][Full Text] [Related]
26. Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C? Veillon P; Fouchard-Hubert I; Larrey D; Dao MT; D'alteroche L; Boyer-Darrigand N; Picard N; Le Guillou-Guillemette H; Saulnier P; Ducancelle A; Loustaud-Ratti V; Lunel-Fabiani F J Interferon Cytokine Res; 2016 Mar; 36(3):204-14. PubMed ID: 26700738 [TBL] [Abstract][Full Text] [Related]
27. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population. Dong ZX; Zhou HJ; Xiang XG; Guo SM; Zhuang Y; Zhao GD; Xie Q J Dig Dis; 2015 Feb; 16(2):90-7. PubMed ID: 25312023 [TBL] [Abstract][Full Text] [Related]
28. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4. Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745 [TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children. Indolfi G; Azzari C; Resti M World J Gastroenterol; 2014 Jul; 20(28):9245-52. PubMed ID: 25071317 [TBL] [Abstract][Full Text] [Related]
31. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment. Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059 [TBL] [Abstract][Full Text] [Related]
32. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684 [TBL] [Abstract][Full Text] [Related]
33. IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin. Meissner EG; Bon D; Prokunina-Olsson L; Tang W; Masur H; O'Brien TR; Herrmann E; Kottilil S; Osinusi A J Infect Dis; 2014 Jun; 209(11):1700-4. PubMed ID: 24367041 [TBL] [Abstract][Full Text] [Related]
34. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients. Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551 [TBL] [Abstract][Full Text] [Related]
35. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans. Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843 [TBL] [Abstract][Full Text] [Related]
36. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection. Jalilian S; Latifi SM; Makvandi M; Teimoori A; Azaran A; Parsanahad M; Kayedani G Indian J Med Microbiol; 2017; 35(2):262-268. PubMed ID: 28681817 [TBL] [Abstract][Full Text] [Related]
37. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant. Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545 [TBL] [Abstract][Full Text] [Related]
38. Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. Estrabaud E; Lapalus M; Broët P; Appourchaux K; De Muynck S; Lada O; Martinot-Peignoux M; Bièche I; Valla D; Bedossa P; Marcellin P; Vidaud M; Asselah T J Virol; 2014 Jun; 88(11):6394-402. PubMed ID: 24672032 [TBL] [Abstract][Full Text] [Related]
39. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population. Rauff B; Amar A; Chudhary SA; Mahmood S; Tayyab GUN; Hanif R Arch Virol; 2021 Apr; 166(4):1047-1056. PubMed ID: 33528661 [TBL] [Abstract][Full Text] [Related]
40. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection. Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]